Cizzle Biotechnology
Non-invasive blood test for early lung cancer detection based on the CIZ1B biomarker, aimed at healthcare providers and patients
Highlights
- New on EvolcAdded 2026-10-28
About Cizzle Biotechnology
Cizzle Biotechnology PLC develops a non-invasive blood test for detecting lung cancer at early stages, based on its patented CIZ1B biomarker and proprietary monoclonal antibodies for an immunoassay. The company says the antibodies pave the way for its first market-ready test.
The target users are healthcare professionals and patients. The company licenses its proprietary technology under royalty-bearing agreements; it has announced licensing and royalty agreements for North America and the Caribbean and a partnership with Moffitt Cancer Center in the USA.
The company was founded in 2004 and originated as a spin-out from the University of York, where the CIZ1B work was developed with the Mammalian Cell Cycle Research Group. Its shares have been listed on the London Stock Exchange since May 2021 under a Standard Listing, and its headquarters are in London. It runs clinical trials and is working toward regulatory approval.
Product: CIZ1B biomarker blood test for early lung cancer detection, using an immunoassay and proprietary monoclonal antibodies
Jobs at Cizzle Biotechnology
Leadership
- Dawn Coverley · Founder and Chief Scientific OfficerSource: company website
- Nigel Lee · Finance DirectorSource: company website
More biotech & pharma companies
CNX Therapeutics
Licenses and distributes specialty medicines for CNS and critical care conditions in 60+ marketsNew on EvolcRemote-friendlyConcinnity Genetics
RNA-based control systems that make gene and cell therapies safer, designed for biopharma developersYoung companyNew on EvolcConstructivebio
Designs and manufactures new-to-nature proteins and peptides for pharmaceutical and industrial partnersNew on EvolcCuraleaf International
Medical cannabis cultivation, manufacturing and distribution for patients, clinics and pharmacies in Europe and beyondNew on EvolcCycle Pharmaceuticals
Rare disease medicines and patient support programmes for oncology, neurology, metabolic and immunology conditionsNew on EvolcRemote-friendlyCyden
Manufacturer of energy-based at-home skin and hair devices for consumer and professional beauty marketsNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Apache
- Elementor
- Google Analytics 4
- Google reCAPTCHA
- PHP
- WooCommerce
- WordPress
- jQuery